|
JPS58201994A
(ja)
|
1982-05-21 |
1983-11-25 |
Hideaki Hagiwara |
抗原特異的ヒト免疫グロブリンの生産方法
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
AU665190B2
(en)
|
1990-07-10 |
1995-12-21 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
DK0546073T3
(da)
|
1990-08-29 |
1998-02-02 |
Genpharm Int |
Frembringelse og anvendelse af transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
|
|
WO1994025585A1
(en)
|
1993-04-26 |
1994-11-10 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
DE69229477T2
(de)
|
1991-09-23 |
1999-12-09 |
Cambridge Antibody Technology Ltd., Melbourn |
Methoden zur Herstellung humanisierter Antikörper
|
|
ATE297465T1
(de)
|
1991-11-25 |
2005-06-15 |
Enzon Inc |
Verfahren zur herstellung von multivalenten antigenbindenden proteinen
|
|
ES2341666T3
(es)
|
1991-12-02 |
2010-06-24 |
Medimmune Limited |
Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
|
|
EP0746609A4
(en)
|
1991-12-17 |
1997-12-17 |
Genpharm Int |
NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
|
|
JP3507073B2
(ja)
|
1992-03-24 |
2004-03-15 |
ケンブリッジ アンティボディー テクノロジー リミティド |
特異的結合対の成員の製造方法
|
|
EP0652950B1
(en)
|
1992-07-24 |
2007-12-19 |
Amgen Fremont Inc. |
Generation of xenogeneic antibodies
|
|
US5573924A
(en)
*
|
1992-09-08 |
1996-11-12 |
Immunex Corporation |
CD27 ligand
|
|
US5648267A
(en)
|
1992-11-13 |
1997-07-15 |
Idec Pharmaceuticals Corporation |
Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
|
|
GB9313509D0
(en)
|
1993-06-30 |
1993-08-11 |
Medical Res Council |
Chemisynthetic libraries
|
|
AU690171B2
(en)
|
1993-12-03 |
1998-04-23 |
Medical Research Council |
Recombinant binding proteins and peptides
|
|
AU701342B2
(en)
|
1994-07-13 |
1999-01-28 |
Chugai Seiyaku Kabushiki Kaisha |
Reconstituted human antibody against human interleukin-8
|
|
BR9713294A
(pt)
|
1996-09-26 |
2000-10-17 |
Chugai Pharmaceutical Co Ltd |
"anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"
|
|
AU3657899A
(en)
|
1998-04-20 |
1999-11-08 |
James E. Bailey |
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
|
|
US6852318B1
(en)
|
1998-05-08 |
2005-02-08 |
The Regents Of The University Of California |
Methods for detecting and inhibiting angiogenesis
|
|
EP2275540B1
(en)
|
1999-04-09 |
2016-03-23 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
|
CA2424602C
(en)
|
2000-10-06 |
2012-09-18 |
Kyowa Hakko Kogyo Co., Ltd. |
Antibody composition-producing cell
|
|
CA2427858A1
(en)
|
2000-11-03 |
2002-05-10 |
University Of Vermont And State Agricultural College |
Compositions for inhibiting grb7
|
|
CA2402459A1
(en)
|
2000-12-01 |
2002-06-06 |
Central Institute For Experimental Animals |
Method of producing a mouse suitable for engraftment, differentiation and proliferation of heterologous cells, mouse produced by this method and use of the mouse
|
|
CA2442801A1
(en)
|
2001-04-02 |
2002-10-10 |
Idec Pharmaceutical Corporation |
Recombinant antibodies coexpressed with gntiii
|
|
AU2003238897A1
(en)
*
|
2002-06-05 |
2003-12-22 |
Avalon Pharmaceuticals, Inc. |
Cancer-linked gene as target for chemotherapy
|
|
US7393531B2
(en)
|
2003-01-21 |
2008-07-01 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of MCSP
|
|
WO2006113909A2
(en)
*
|
2005-04-19 |
2006-10-26 |
Seattle Genetics, Inc. |
Humanized anti-cd70 binding agents and uses thereof
|
|
CA2525909A1
(en)
|
2003-05-16 |
2004-11-25 |
Kyowa Hakko Kogyo Co., Ltd. |
Novel stem cell derived from adult tissue and use thereof
|
|
JP2005035943A
(ja)
|
2003-07-16 |
2005-02-10 |
Chemo Sero Therapeut Res Inst |
悪性腫瘍細胞増殖抑制剤
|
|
CA2447400A1
(en)
|
2003-09-12 |
2005-03-12 |
The Hospital For Sick Children |
Brain tumor stem cells
|
|
WO2005035740A1
(ja)
|
2003-10-09 |
2005-04-21 |
Kyowa Hakko Kogyo Co., Ltd. |
無血清馴化したゲノム改変細胞
|
|
JP2005206508A
(ja)
*
|
2004-01-22 |
2005-08-04 |
Chemo Sero Therapeut Res Inst |
悪性腫瘍細胞増殖抑制抗体
|
|
CA2560742A1
(en)
*
|
2004-03-23 |
2005-10-06 |
Biogen Idec Ma Inc. |
Receptor coupling agents and therapeutic uses thereof
|
|
WO2005111076A1
(en)
*
|
2004-05-12 |
2005-11-24 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Nectin 4 (n4) as a marker for cancer prognosis
|
|
US20080152700A1
(en)
|
2004-06-01 |
2008-06-26 |
Reza Sheikhnejad |
Methods and compositions for the inhibition of gene expression
|
|
WO2006014999A2
(en)
*
|
2004-07-27 |
2006-02-09 |
Five Prime Therapeutics, Inc. |
Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease
|
|
WO2006039671A2
(en)
|
2004-09-29 |
2006-04-13 |
Central Institute For Experimental Animals |
Gene markers of tumor metastasis
|
|
WO2006051405A2
(en)
|
2004-11-12 |
2006-05-18 |
Cambridge University Technical Services Ltd. |
Methods and means related to cancer stem cells
|
|
US20090081221A1
(en)
|
2004-11-15 |
2009-03-26 |
Kirin Beer Kabushiki Kaisha |
Method for suppressing cancer cell metastasis and pharmaceutical composition for use in the method
|
|
WO2006138275A2
(en)
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
EP1907572A2
(en)
|
2005-07-26 |
2008-04-09 |
Procure Therapeutics Limited |
Prostate stem cell markers
|
|
EA016186B1
(ru)
*
|
2005-09-26 |
2012-03-30 |
Медарекс, Инк. |
Человеческие моноклональные антитела к cd70 и их применение
|
|
AU2006308847C1
(en)
|
2005-10-31 |
2012-05-10 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for treating and diagnosing cancer
|
|
US20070220621A1
(en)
|
2005-10-31 |
2007-09-20 |
Clarke Michael F |
Genetic characterization and prognostic significance of cancer stem cells in cancer
|
|
ES2548240T3
(es)
|
2005-12-01 |
2015-10-15 |
Pronai Therapeutics, Inc. |
Terapias para el cáncer y composiciones farmacéuticas usadas en las mismas
|
|
EP1792979A1
(en)
|
2005-12-01 |
2007-06-06 |
Stiftung Caesar Center of Advanced European Studies and Research |
Cell culture system for the enrichment and expansion of stem cells
|
|
WO2007124125A2
(en)
*
|
2006-04-21 |
2007-11-01 |
Stowers Institute For Medical Research |
Methods of identifying stem cells in normal and cancerous tissues and related progeny cells
|
|
WO2007132883A1
(ja)
|
2006-05-17 |
2007-11-22 |
Yokohama City University |
肝臓癌の鑑別、疾患ステージの判定又は予後の予測方法及びキット
|
|
WO2007145901A1
(en)
|
2006-06-06 |
2007-12-21 |
University Of Tennessee Research Foundation |
Compositions enriched in neoplastic stem cells and methods comprising same
|
|
WO2009045201A1
(en)
*
|
2006-08-02 |
2009-04-09 |
Biogen Idec Ma Inc. |
Cancer stem cells
|
|
WO2008017171A1
(en)
|
2006-08-11 |
2008-02-14 |
Ao-Forschungsinstitut Davos |
Identification and selection of stem cells being committed to differentiate to a specific type for obtaining a homogeneous population of stem cells
|
|
JP2010502220A
(ja)
*
|
2006-09-05 |
2010-01-28 |
メダレックス インコーポレーティッド |
骨形態形成タンパク質およびその受容体に対する抗体ならびにその使用方法
|
|
WO2008033393A2
(en)
|
2006-09-11 |
2008-03-20 |
University Of Florida |
Isolation, expansion and uses of tumor stem cells
|
|
GB2442059A
(en)
|
2006-09-19 |
2008-03-26 |
Ist Superiore Sanita |
Test for cancer of the gastrointestinal tract
|
|
AU2007312367B2
(en)
*
|
2006-10-12 |
2012-09-06 |
Chugai Seiyaku Kabushiki Kaisha |
Diagnosis and treatment of cancer using anti-EREG antibody
|
|
JP2008102012A
(ja)
|
2006-10-19 |
2008-05-01 |
Kanazawa Univ |
癌幹細胞の同定および単離方法
|
|
EP2109668A4
(en)
|
2007-01-22 |
2011-10-05 |
Macrogenics West Inc |
HUMAN CANCER STEM CELLS
|
|
JP2008182912A
(ja)
|
2007-01-29 |
2008-08-14 |
Nippon Kayaku Co Ltd |
癌幹細胞の培養方法、および癌幹細胞
|
|
NZ581395A
(en)
*
|
2007-05-14 |
2012-08-31 |
Biogen Idec Inc |
Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
|
|
WO2008149803A1
(ja)
|
2007-06-06 |
2008-12-11 |
The University Of Tokyo |
表面抗原マーカーを用いた急性リンパ性白血病における癌幹細胞の分離同定方法
|
|
JP5931336B2
(ja)
|
2007-07-02 |
2016-06-08 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
がんを処置および診断するための組成物および方法
|
|
US20110244502A1
(en)
|
2007-08-10 |
2011-10-06 |
Whitehead Institute For Biomedical Research |
Hormone responsive tissue culture system and uses thereof
|
|
EP2022848A1
(en)
|
2007-08-10 |
2009-02-11 |
Hubrecht Institut |
A method for identifying, expanding, and removing adult stem cells and cancer stem cells
|
|
GB2465940A
(en)
|
2007-10-01 |
2010-06-09 |
Hospital For Sick Children |
Neural tumor stem cells and methods of use thereof
|
|
WO2009064301A1
(en)
*
|
2007-11-15 |
2009-05-22 |
The Johns Hopkins University |
Methods for detecting and monitoring circulating cancer stem cells
|
|
US20100267571A1
(en)
|
2007-12-14 |
2010-10-21 |
Chugai Seiyaku Kabushiki Kaisha |
Novel method for specimen preparation, which ensures preservation of tissue morphology and nucleic acid quality
|
|
WO2009111067A2
(en)
|
2008-03-07 |
2009-09-11 |
Osi Pharmaceuticals, Inc. |
Methods for the identification of agents that inhibit mesenchymal -like tumor cells or their formation
|
|
WO2009135181A2
(en)
*
|
2008-05-02 |
2009-11-05 |
Seattle Genetics, Inc. |
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
|
|
WO2010009121A2
(en)
|
2008-07-15 |
2010-01-21 |
University Of Florida Research Foundation, Inc. |
Colon stem cells associated with colitis and colorectal cancer and methods of use
|
|
WO2010016766A2
(en)
|
2008-08-08 |
2010-02-11 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Antibodies recognizing endogenous human lgr5 and/or lgr6
|
|
WO2010067487A1
(en)
*
|
2008-12-12 |
2010-06-17 |
Oncotherapy Science, Inc. |
Nectin-4 for target genes of cancer therapy and diagnosis
|
|
CN102405237A
(zh)
*
|
2009-03-06 |
2012-04-04 |
卡罗拜奥斯制药公司 |
利用EphA3抗体治疗白血病和慢性骨髓增生性疾病
|
|
EP2414396B1
(en)
*
|
2009-03-30 |
2015-02-25 |
Edimer Biotech S.a. |
Preparation of isolated agonist anti-edar monoclonal antibodies
|
|
JP2012524083A
(ja)
*
|
2009-04-20 |
2012-10-11 |
ジェネンテック, インコーポレイテッド |
アジュバント癌治療
|
|
TW201105347A
(en)
*
|
2009-04-28 |
2011-02-16 |
Chugai Pharmaceutical Co Ltd |
Pharmaceutical compositions for maintenance therapy containing HLA class I-recognizing antibody as the active ingredient
|
|
US20120141501A1
(en)
*
|
2009-05-29 |
2012-06-07 |
Forerunner Pharma Research Co. Ltd |
Pharmaceutical Composition Containing Antagonist of EGF Family Ligand as Component
|
|
WO2011027308A1
(en)
|
2009-09-03 |
2011-03-10 |
Koninklijke Philips Electronics N.V. |
Novel tumor markers
|
|
JP5808054B2
(ja)
|
2009-12-25 |
2015-11-10 |
中外製薬株式会社 |
Nog樹立癌細胞株が移植された非ヒト動物モデルを用いた抗癌剤ターゲット探索及びスクリーニング法
|
|
US9217032B2
(en)
|
2010-01-08 |
2015-12-22 |
Les Laboratoires Servier |
Methods for treating colorectal cancer
|
|
CN103328626B
(zh)
|
2010-10-06 |
2017-02-08 |
中外制药株式会社 |
癌干细胞群及其制备方法
|
|
KR101463182B1
(ko)
*
|
2011-01-13 |
2014-11-21 |
연세대학교 산학협력단 |
췌장암 암줄기세포 특성을 이용한 췌장암 신규 바이오마커 및 그의 용도
|
|
WO2013002362A1
(ja)
|
2011-06-30 |
2013-01-03 |
中外製薬株式会社 |
ヘテロ二量化ポリペプチド
|
|
JP6077997B2
(ja)
|
2011-09-07 |
2017-02-08 |
中外製薬株式会社 |
癌幹細胞の分離
|
|
EP3603671A3
(en)
|
2011-10-28 |
2020-07-29 |
Chugai Seiyaku Kabushiki Kaisha |
Cancer stem cell-specific molecule
|
|
TWI593705B
(zh)
|
2011-12-28 |
2017-08-01 |
Chugai Pharmaceutical Co Ltd |
Humanized anti-epiregulin antibody and cancer therapeutic agent containing the antibody as an active ingredient
|
|
WO2014104165A1
(ja)
|
2012-12-27 |
2014-07-03 |
中外製薬株式会社 |
ヘテロ二量化ポリペプチド
|
|
US10504315B2
(en)
|
2013-08-05 |
2019-12-10 |
Ncr Corporation |
Clamping of media items
|